Meetings 
Student rates 
In the U.S., the system designed to protect Americans from the financial devastation of illness often ends up being the very source of that devastation. While it can be...
CAPRA BENEFITS
The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is an organization dedicated to providing its members with opportunities to enhance their professional development and maximize career opportunities. Whether you are a student, an entry-level associate or an experienced executive, a membership with CAPRA is a must.
We foster learning, networking and professional excellence of our members. We will build and strengthen relationships with governmental agencies, scientific experts and industry educators in order to create an affordable, professionally fulfilling and academically enriching environment for our members.
WHY JOIN CAPRA AS A STUDENT?
Introduction to Regulatory Affairs and the Regulatory Affairs Profession
LEARN MORE
ADVERTISE WITH CAPRA
Reach CAPRA members through the NOC (News of Course), or place an employment ad in our listings.
LEARN MOREEMPLOYMENT LISTINGS
Available to CAPRA Members
Planning to place an employment advertisement through CAPRA/ACRP? Looking for a new career opportunity? If so, you have come to the right place! CAPRA now has over 900 members in the regulatory affairs field!
Job Seekers: Scroll through our most recent postings, your dream job maybe at your fingers tips!
Employers: Regulatory professionals are difficult to find. Win the competition for talent, by advertising in CAPRA. Our email employment notice service brings you access to hundreds of top class, experienced professionals. One of them may be just whom you are looking for!
VIEW OPPORTUNITIESCAPRA BLOG
Value-Based Drug Pricing in Canada and its Limitations
Drug pricing is a complex and controversial issue that often sparks debates among patients, pharmaceutical companies, and the government. Prices can vary significantly...
Addressing Underrepresentation in Clinical Trials: FDA's Diversity Action Plan
The U.S. Food and Drug Administration (FDA) released a new draft guidance in June 2024 to enhance the diversity of clinical trial participants. The guidance details the...